Director of Commerce of Washington State Rogers Weed, left, joins CMC Biologics officials David Kauffmann and Gustavo Mahler at the CMC Biologics opening of its state-of-the-art biopharmaceutical manufacturing facility in Bothell Sept. 21. The expansion of PF2 duplicates capacity and supports commercial manufacturing.
CMC Biologics is a contract manufacturing organization that offers solutions to the challenges faced in developing bio-processes and in manufacturing biological therapeutics for clinical trial and commercial supplies. The company has facilities in Bothell and Copenhagen, Denmark.
